|
Hi runtolive;
With regard to the trials of Herceptin, it appears that this from what you say only applies to Her2+ with metastatic cancer.
Is this correct as far as you know? I ask because I do not have metastatic cancer, had 1 positive lymph node. When I asked my oncologist, her response was that the study that is being done - the result/data should be in just as I will be completing Herceptin next Nov. I sort of got the impression that there is a possibility that I will continue on Herceptin for an additional year should the data prove that it is beneficial. There was no discussion with regard to my not having metastatic cancer. So, now I am quite confused. I will not see my oncologist till the end of January so cannot ask for more clarification.
And, good for you that you know as much as you do, where do you find all of this important information? Or, better question, how???
Thanks for clarifying...
Happy Holidays to you filled with good health for the New Year.
robind
|